Buckeye State Dispatch
SEE OTHER BRANDS

Your daily news update on Ohio

Buckeye State Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Buckeye State Dispatch.

Press releases published on July 2, 2025

Toke and Float 2025 Festival Returns to Kim Tam Park in Just 10 Days with ǝKoostik Hookah Headlining

Toke and Float 2025 Festival Returns to Kim Tam Park in Just 10 Days with ǝKoostik Hookah Headlining

Toke and Float 2025 kicks off July 12 in Uniontown, OH, with live music, floating, and cannabis-friendly vibes. ǝKoostik Hookah headlines the event. UNIONTOWN, OH, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Final Countdown Begins: Toke and Float …

Russell Tillery Joins Verti Commercial Real Estate as Director

Russell Tillery Joins Verti Commercial Real Estate as Director

COLUMBUS, OH, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Verti Commercial Real Estate, the brokerage reshaping the commercial real estate experience through strategy and innovation, proudly welcomes Russell Tillery as its newest Director. …

reAlpha Enhances Mortgage Operations with AI-Powered Loan Officer Assistant

reAlpha Enhances Mortgage Operations with AI-Powered Loan Officer Assistant

DUBLIN, Ohio, July 02, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced the launch of its AI-powered Internal Loan Officer Assistant. This newly released …

O-I Glass Announces Second Quarter 2025 Earnings Conference Call and Webcast

O-I Glass Announces Second Quarter 2025 Earnings Conference Call and Webcast

PERRYSBURG, Ohio, July 02, 2025 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (NYSE: OI) has scheduled its second quarter 2025 conference call and webcast for Wednesday, July 30, 2025, at 8 a.m. EDT. The Company’s news release for the second quarter 2025 earnings …

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $155 million on June 27, 2025. Including net …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service